Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse

Breast

Volumn 15, Issue 1, 2006, Pages 97-99

  Hikino, Hajime ^a   Yamada, Takako ^a   Johbara, Kanta ^a   Obayashi, Nobuhiko ^a   Ozaki, Nobuhiro ^a  

^a SHIMANE PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Breast cancer; Capecitabine; CNS metastasis; Meningeal carcinomatosis

Indexed keywords

CAPECITABINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CASE REPORT; CENTRAL NERVOUS SYSTEM METASTASIS; DISEASE COURSE; DRUG RESPONSE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; MENINGEAL METASTASIS; MONOTHERAPY; NAUSEA AND VOMITING; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 32244444254     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.03.006     Document Type: Article

References (16)

1. G.C. Jayson A. Howell M. Harris G. Morgenstern J. Chang W.D. Ryder Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant Cancer 74 1994 3135-3141
2. J.P. Posner Neurologic complications of cancer 1995 Davis Philadelphia, PA p. 143
3. D. Crivellari O. Pagani A. Veronesi et al. High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel Ann Oncol 12 2001 353-356
4. L.M. DeAngelis Current diagnosis and treatment of leptomeningeal metastasis J Neurooncol 38 1998 245-252
5. T. Siegal Toxicity of treatment for neoplastic meningitis Curr Oncol Rep 5 2003 41-49
6. F. Bokstein A. Lossos T. Siegal Leptomeningeal metastases from solid tumors: A comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy Cancer 82 1998 1756-1763
7. M. Miwa M. Ura M. Nishida et al. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1998 1274-1281
8. A.D. Seidman M. Aapro Incorporating oral capecitabine into the treatment of breast cancer. Introduction Oncologist 7 Suppl. 6 2002 1-3
9. J.L. Blum S.E. Jones A.U. et al. Buzdar Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer J Clin Oncol 17 1999 485-493
10. McEvoy GK, editor. Capecitabine. In: AHFS drug information. Bethesda, MD: American Society of Health-System Pharmacists; 2002. p. 916-21.
11. M.S. Heier R. Heintz S.D. Fossa Passage of 5′-dFUrd and its metabolites 5-FU and 5-FUH2 to CSF in a clinical phase 1 study Acta Neurol Scand 74 1986 240-244
12. M.L. Wang W.K. Yung M.E. Royce D.F. Schomer R.L. Theriault Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer Am J Clin Oncol 24 2001 421-424
13. P. Giglio I.W. Tremont-Lukats M.D. Groves Response of neoplastic meningitis from solid tumors to oral capecitabine J Neurooncol 65 2003 167-172
14. L.R. Rogers S.E. Remer S. Tejwani Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy Neurooncology 6 2004 63-64
15. N. Siegelmann-Danieli M. Stein J. Bar-Ziv Complete response of brain metastases originating in breast cancer to capecitabine therapy Isreal Med Assoc J 5 2003 833-834
16. D.A. Collie J.P. Brush G.A. et al. Lammie Imaging features of leptomeningeal metastases Clin Radiol 54 1999 765-771